One of the cornerstones of precision public health in cancer is the use of genomic data. By understanding the genetic predispositions that contribute to cancer risk, public health officials can develop more targeted screening programs and personalize prevention strategies. For example, individuals with BRCA mutations can be offered more frequent screenings or preventive surgeries to reduce their risk of developing breast or ovarian cancer.